The introduction of nicotinamide for a nicotine substitute in e-cigarette and smokeless items signifies an important regulatory obstacle to the FDA. Nicotinamide doesn't have nicotinic receptor agonist action and is thought to work as a sedative at large dosages6. The statements made by Nicotine River, ECBlend, as well as other suppliers that their